Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Caring & giving/
  4. Ensuring babies have the first breath of life
Our-Giving-Ensuring-Babies-Have-the-First-Breath-of-Life
When Sun Yan’s daughter Wu Yuxuan was born, she could not breathe on her own until nurses performed life-giving resuscitation.

Ensuring babies have the first breath of life

When Sun Yan’s daughter Wu Yuxuan was born, she could not breathe on her own until nurses performed life-giving resuscitation.

The Helping Babies Breathe (HBB) initiative trains health care workers in low-resource settings to intervene when newborns have birth asphyxia, the inability to breathe at birth. HBB is committed to increase the availability of skilled birth attendants at every birth. Nurses and midwives with HBB training have the skills to resuscitate over 90% of babies with birth asphyxia.

In 2011, Johnson & Johnson made a $2 million 5-year investment to implement HBB in Malawi and Uganda in partnership with Save the Children. The partnership has trained more than 1000 skilled birth attendants, mostly midwives.

HBB is an extension of over a decade of work with the Neonatal Resuscitation Program to address birth asphyxia, including a joint effort in China by Johnson & Johnson, the Chinese Ministry of Health and the American Academy of Pediatrics that has saved more than 190,000 babies. Since the program launched in 2004, newborn death caused by birth asphyxia has declined in China by more than 50% percent.

To date, our programs address birth asphyxia in more than 12 countries including China, India, Indonesia, Vietnam, Nepal, Pakistan, Uganda, Malawi, Kenya, Ethiopia, Ghana and South Africa.

More from Johnson & Johnson

What’s the difference between IBS and IBD?

These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

6 ways Johnson & Johnson is using AI to help advance healthcare

Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.